Bullous pemphigoid in a patient with a neuropsychological disorder and a possible novel drug trigger: A case report and review of the literature
Abstract A 59‐year‐old woman with schizoaffective disorder presented with an itchy, blistering generalised rash. One month prior, she had started empagliflozin, a sodium glucose transporter‐2 (SGLT‐2) inhibitor, used in type‐2‐diabetes. She was already established on paliperidone, an atypical antips...
Saved in:
Main Authors: | Sarah M. Dyson (Author), Priya U. Patel (Author), Laszlo Igali (Author), George W. M. Millington (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bullous pemphigoid triggered by dulaglutide: a case report and a review of the literature
by: Benedetta Sonego, et al.
Published: (2023) -
A Case of Bullous Rash Apparently Triggered by Meningococcal and Rotavirus Vaccines in an Infant: Focus on Infantile Bullous Pemphigoid
by: Iria Neri, et al.
Published: (2021) -
Bullous Pemphigoid-like Eruption Triggered by Targeted Therapy for Metastatic Melanoma
by: Hanna Eriksson, et al.
Published: (2020) -
Bullous pemphigoid
by: Denise Miyamoto, et al. -
New-onset bullous pemphigoid triggered by AstraZeneca COVID-19 vaccine
by: Yin-Cheng Chao, et al.
Published: (2022)